Spine company Benvenue Medical Inc. (Santa Clara, Calif.) completed a $60 million round of financing that the company said will be spent on accelerating U.S. commercialization activities for its Luna 3-D interbody fusion system and the Kiva vetebral compression fracture treatment system. The FDA cleared both products in 2014. The financing is a combination of $23 million in equity from existing investors supplemented with $37 million in debt. This latest round follows a $64 million debt and equity round in 2014, a $25 million series D round in 2012 and a $35.5 million series C financing in 2011.